Literature DB >> 24283592

The human side of failed hypertension treatment.

Michael A Weber1, Suzanne Oparil.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24283592      PMCID： PMC8033794          DOI： 10.1111/jch.12175

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  18 in total

1.  The effect of lowering blood pressure on quality of life.

Authors:  C J Bulpitt
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

2.  Resistant hypertension? Assessment of adherence by toxicological urine analysis.

Authors:  Oliver Jung; Janis L Gechter; Cora Wunder; Alexander Paulke; Christine Bartel; Helmut Geiger; Stefan W Toennes
Journal:  J Hypertens       Date:  2013-04       Impact factor: 4.844

3.  Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events, and prior antihypertensive therapy.

Authors:  M R Weir; L M Prisant; V Papademetriou; M A Weber; I A Adegbile; D Alemayehu; M P Lefkowitz
Journal:  Am J Hypertens       Date:  1996-09       Impact factor: 2.689

4.  Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.

Authors:  Rhonda M Cooper-DeHoff; Yan Gong; Eileen M Handberg; Anthony A Bavry; Scott J Denardo; George L Bakris; Carl J Pepine
Journal:  JAMA       Date:  2010-07-07       Impact factor: 56.272

5.  Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Circulation       Date:  2008-06-24       Impact factor: 29.690

6.  Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study.

Authors:  Peter Sleight; Josep Redon; Paolo Verdecchia; Giuseppe Mancia; Peggy Gao; Robert Fagard; Helmut Schumacher; Michael Weber; Michael Böhm; Bryan Williams; Janice Pogue; Teo Koon; Salim Yusuf
Journal:  J Hypertens       Date:  2009-07       Impact factor: 4.844

7.  Awareness, knowledge, and attitudes of older americans about high blood pressure: implications for health care policy, education, and research.

Authors:  Brent M Egan; Daniel T Lackland; Neal E Cutler
Journal:  Arch Intern Med       Date:  2003-03-24

8.  Patients with treatment-resistant hypertension report increased stress and anxiety: a worldwide study.

Authors:  Roland E Schmieder; Guido Grassi; Sverre E Kjeldsen
Journal:  J Hypertens       Date:  2013-03       Impact factor: 4.844

Review 9.  Hypertension 2008--awareness, understanding, and treatment of previously diagnosed hypertension in baby boomers and seniors: a survey conducted by Harris interactive on behalf of the Preventive Cardiovascular Nurses Association.

Authors:  Nancy H Miller; Kathy Berra; Janet Long
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-05       Impact factor: 3.738

10.  Quality of life measured in a practice-based hypertension trial of an angiotensin receptor blocker.

Authors:  Michael A Weber; George L Bakris; Joel M Neutel; Giora Davidai; Thomas D Giles
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Sep-Oct       Impact factor: 3.738
View more
  1 in total

1.  The evolving clinical management of hypertension.

Authors:  Michael A Weber
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-11-10       Impact factor: 3.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.